🇮🇳IN
Sign In
SH

SHUKRAPHAR

NSE

Shukra Medtech Ltd

₹82.22

+0.02(+0.02%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector−₹5,497 Crnet foreign selling
2026-10-01 to 2026-10-15

This is the flow into the whole Healthcare sector, not into SHUKRAPHAR. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

SHUKRAPHAR exposure summary

In its latest segment disclosure (Sep 2026), Pharamaceutical segment was the largest segment at 72.1% of segment revenue, followed by Medtech segment at 27.9%. Shukra Medtech Ltd is a constituent of 2 indices.

Index memberships2
Largest segmentPharamaceutical segment · 72.1%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer